Orpheus Uranium Maintains Strong Cash Position to Support Exploration
Orpheus Uranium Limited (ASX: ORP) finished the June 2026 quarter with cash and cash equivalents of AU$4.96 million, providing a solid financial base to continue progressing its uranium exploration portfolio. During the period, the company recorded a net operating cash outflow of AU$422,000, primarily driven by employee, administrative, and corporate expenses. Exploration and evaluation activities accounted for AU$356,000 in expenditure, reflecting the company's continued focus on advancing its projects. Investing activities generated a net inflow of AU$294,000 following proceeds from the disposal of investments, while no new equity or debt funding was secured during the quarter. The cash balance eased slightly from AU$5.09 million at the start of the period, demonstrating measured spending and effective cash management. Based on its current expenditure profile, the company has an estimated funding runway of 6.49 quarters, indicating a comfortable liquidity position to support ongoing exploration programs without an immediate need to raise additional capital.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Orpheus Uranium Maintains Strong Cash Position to Support Exploration
Orpheus Uranium Limited (ASX: ORP) finished the June 2026 quarter with cash and cash equivalents of AU$4.96 million, providing a solid financial base to continue progressing its uranium exploration portfolio. During the period, the company recorded a net operating cash outflow of AU$422,000, primarily driven by employee, administrative, and corporate expenses. Exploration and evaluation activities accounted for AU$356,000 in expenditure, reflecting the company's continued focus on advancing its projects. Investing activities generated a net inflow of AU$294,000 following proceeds from the disposal of investments, while no new equity or debt funding was secured during the quarter. The cash balance eased slightly from AU$5.09 million at the start of the period, demonstrating measured spending and effective cash management. Based on its current expenditure profile, the company has an estimated funding runway of 6.49 quarters, indicating a comfortable liquidity position to support ongoing exploration programs without an immediate need to raise additional capital.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au